Please use this identifier to cite or link to this item:
http://hdl.handle.net/11375/26514Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Ye Z | - |
| dc.contributor.author | Rochwerg B | - |
| dc.contributor.author | Wang Y | - |
| dc.contributor.author | Adhikari NK | - |
| dc.contributor.author | Murthy S | - |
| dc.contributor.author | Lamontagne F | - |
| dc.contributor.author | Fowler RA | - |
| dc.contributor.author | Qiu H | - |
| dc.contributor.author | Wei L | - |
| dc.contributor.author | Sang L | - |
| dc.contributor.author | Loeb M | - |
| dc.contributor.author | Shen N | - |
| dc.contributor.author | Huang M | - |
| dc.contributor.author | Jiang Z | - |
| dc.contributor.author | Arabi YM | - |
| dc.contributor.author | Colunga-Lozano LE | - |
| dc.contributor.author | Jiang L | - |
| dc.contributor.author | Koh Y | - |
| dc.contributor.author | Liu D | - |
| dc.contributor.author | Liu F | - |
| dc.contributor.author | Phua J | - |
| dc.contributor.author | Shen A | - |
| dc.contributor.author | Huo T | - |
| dc.contributor.author | Du B | - |
| dc.contributor.author | Zhai S | - |
| dc.contributor.author | Guyatt GH | - |
| dc.date.accessioned | 2021-06-07T15:46:34Z | - |
| dc.date.available | 2021-06-07T15:46:34Z | - |
| dc.date.issued | 2020-05-19 | - |
| dc.identifier.issn | 0820-3946 | - |
| dc.identifier.issn | 1488-2329 | - |
| dc.identifier.uri | http://hdl.handle.net/11375/26514 | - |
| dc.publisher | CMA Joule Inc. | - |
| dc.rights | Attribution-NonCommercial-NoDerivs - CC BY-NC-ND This license is the most restrictive of the main Creative Commons licenses, only allowing others to download your works and share them with others as long as they credit you, but they can?t change them in any way or use them commercially. | - |
| dc.rights.uri | 7 | - |
| dc.subject | Adrenal Cortex Hormones | - |
| dc.subject | Antiviral Agents | - |
| dc.subject | COVID-19 | - |
| dc.subject | Coronavirus Infections | - |
| dc.subject | Evidence-Based Medicine | - |
| dc.subject | Humans | - |
| dc.subject | Pandemics | - |
| dc.subject | Plasma | - |
| dc.subject | Pneumonia, Viral | - |
| dc.subject | Practice Guidelines as Topic | - |
| dc.subject | Severity of Illness Index | - |
| dc.title | Treatment of patients with nonsevere and severe coronavirus disease 2019: an evidence-based guideline | - |
| dc.type | Article | - |
| dc.date.updated | 2021-06-07T15:46:34Z | - |
| dc.rights.license | Attribution-NonCommercial-NoDerivs - CC BY-NC-ND | - |
| dc.identifier.doi | https://doi.org/10.1503/cmaj.200648 | - |
| Appears in Collections: | Faculty Publications (via McMaster Experts) | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| E536.full.pdf | Published version | 103.97 kB | Adobe PDF | View/Open |
Items in MacSphere are protected by copyright, with all rights reserved, unless otherwise indicated.
